Fixed-dose combination treatment after stroke for secondary prevention in China: a national community-based study

Stroke; a Journal of Cerebral Circulation
Wang LongdeZhao Dong

Abstract

There is evidence and international consensus on the advantages and potential of a polypill for established cardiovascular disease patients to improve adherence in the secondary prevention of cardiovascular disease. This study aimed to estimate the numbers of stroke patients who would be eligible for the polypill strategy in China, and the suitable composition of a polypill, based on data of the China National Stroke Prevention Project. A total of 717 620 residents aged ≥40 years from 6 Chinese representative provinces were screened for prevalent stroke from 2011 to 2012 with an 84.4% response rate. Participants with a history of stroke received further investigation of risk factors and treatments. The potential need for treatment was classified according to the guidelines. Rates were standardized using the population composition of the Sixth National Population Census of China. The standardized prevalence rate of stroke was 1.9%. Up to 93.1% of stroke patients were eligible for a polypill containing at least 2 types of medications, with 75.3% eligible for a statin and antiplatelet agent and 70.6% for antihypertensive and antiplatelet medications. Considering 3 therapies, 54% were eligible for antihypertensive, statin, and anti...Continue Reading

References

Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Mar 7, 2008·Stroke; a Journal of Cerebral Circulation·Robert J AdamsUNKNOWN American Stroke Association
Oct 23, 2010·Stroke; a Journal of Cerebral Circulation·Karen L FurieUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisci
Sep 5, 2013·JAMA : the Journal of the American Medical Association·J Michael Gaziano
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Simon ThomUNKNOWN UMPIRE Collaborative Group
Oct 9, 2013·Nature Reviews. Cardiology·Ginés Sanz, Valentin Fuster
Dec 10, 2013·Journal of Clinical Lipidology·UNKNOWN Expert Dyslipidemia Panel, Scott M Grundy
Jan 5, 2014·Stroke; a Journal of Cerebral Circulation·Bin PengUNKNOWN SMART Investigators
Feb 25, 2014·Journal of the American College of Cardiology·Mark D Huffman, Salim Yusuf
May 3, 2014·Stroke; a Journal of Cerebral Circulation·Walter N KernanUNKNOWN American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and
Nov 17, 2014·JAMA : the Journal of the American Medical Association·Mark D HuffmanShah Ebrahim

❮ Previous
Next ❯

Citations

Sep 10, 2015·Internal and Emergency Medicine·Zhizhong Gong, Dong Zhao
Oct 28, 2016·Expert Review of Cardiovascular Therapy·Yumei LiuBruce Ovbiagele
Feb 21, 2018·International Journal of Stroke : Official Journal of the International Stroke Society·Michael BraininAnita Wiseman
Oct 22, 2015·Stroke; a Journal of Cerebral Circulation·Anthony S KimNatalie T Cheng
Nov 24, 2018·Nature Reviews. Cardiology·Dong ZhaoMengge Zhou
Sep 9, 2019·Translational Stroke Research·Ying ShenLong-De Wang
Jan 7, 2019·Stroke; a Journal of Cerebral Circulation·Shengde LiUNKNOWN FAST-RIGHT Investigators and Coordinators
Apr 7, 2017·International Journal of Stroke : Official Journal of the International Stroke Society·Yilong WangYongjun Wang
Sep 14, 2019·Brain and Behavior·Shengde LiUNKNOWN FAST-RIGHT Investigators and Coordinators
Nov 14, 2019·BMC Neurology·Shengde LiUNKNOWN FAST-RIGHT Investigators and Coordinators
Apr 1, 2020·International Journal of Stroke : Official Journal of the International Stroke Society·Bao-Hua ChaoLong-De Wang
Sep 8, 2020·Neurological Research·Xiaobo QiuLanying He
Feb 3, 2021·Acta Neurologica Scandinavica·Nanxiang OuyangYingxian Sun
Oct 8, 2018·The American Journal of Cardiology·Jian GuoYuanli Liu
Aug 17, 2021·Chinese Medical Journal·Jing YuanUNKNOWN FAST-RIGHT Investigators and Coordinators
Sep 1, 2021·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Jens LehmannGerhard Rumpold
Oct 11, 2021·Health and Quality of Life Outcomes·Huiqing YaoPeng Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

The Cochrane Database of Systematic Reviews
Angharad N de CatesMark D Huffman
International Journal of Clinical Practice
S J LewisSHIELD Study Group
Nederlands tijdschrift voor geneeskunde
Melvin LafeberDiederick E Grobbee
Stroke; a Journal of Cerebral Circulation
Saran Jonas, Giacinto Grieco
Journal of the American College of Cardiology
Heather L Horton
© 2021 Meta ULC. All rights reserved